FRANK BARTUCCI: Open Payments
NPI 1336621754 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,662 in 214 payments from 32 companies in 2025. Trend: 2023 $264 · 2024 $13 · 2025 $3,662
Food & beverage: $3,580Education: $81
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 31 | $458 |
| Biogen, Inc. | 27 | $322 |
| Lilly USA, LLC | 6 | $289 |
| Eisai Inc. | 15 | $271 |
| ABBVIE INC. | 22 | $263 |
| Teva Pharmaceuticals USA, Inc. | 16 | $244 |
| Otsuka America Pharmaceutical, Inc. | 5 | $209 |
| Novartis Pharmaceuticals Corporation | 13 | $169 |
| Genentech USA, Inc. | 6 | $169 |
| Lundbeck LLC | 15 | $149 |
Products named: KISUNLA, REXULTI, Leqembi, VUMERITY, Briviact, Rystiggo, KESIMPTA, Ocrevus Zunovo.
Industry payments across AZ — which companies pay providers there.
